133 related articles for article (PubMed ID: 3080049)
1. The kidney in myeloma.
Hamblin TJ
Br Med J (Clin Res Ed); 1986 Jan; 292(6512):2-3. PubMed ID: 3080049
[No Abstract] [Full Text] [Related]
2. The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma.
Coward RA; Delamore IW; Mallick NP; Robinson EL
Clin Sci (Lond); 1984 Feb; 66(2):229-32. PubMed ID: 6420108
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin light chain nephropathies.
Sturgill BC; Tucker FL; Bolton WK
Pathol Annu; 1987; 22 Pt 2():133-50. PubMed ID: 3120137
[TBL] [Abstract][Full Text] [Related]
4. [Free immunoglobulin L chains].
Numata Y
Rinsho Byori; 1983 May; 31(5):489-95. PubMed ID: 6415322
[No Abstract] [Full Text] [Related]
5. Renal failure as the presenting feature of light chain myeloma of kappa type.
Raina V; Veluchamy K; Kumar R; Malaviya AN
J Assoc Physicians India; 1982 Sep; 30(9):636-8. PubMed ID: 6820955
[No Abstract] [Full Text] [Related]
6. Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group.
Pasquali S; Zucchelli P; Casanova S; Cagnoli L; Confalonieri R; Pozzi C; Banfi G; Lupo A; Bertani T
Clin Nephrol; 1987 May; 27(5):222-8. PubMed ID: 3109793
[TBL] [Abstract][Full Text] [Related]
7. Light chain multiple myeloma in a patient with long-standing rheumatoid arthritis.
Alexopoulou A; Dourakis SP; Apostolopoulou A; Kandyli A; Pandelidaki H; Archimandritis AJ
Clin Rheumatol; 2005 Nov; 24(6):669-70. PubMed ID: 15856363
[No Abstract] [Full Text] [Related]
8. Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.
Johns EA; Turner R; Cooper EH; Maclennan IC
J Clin Pathol; 1986 Aug; 39(8):833-7. PubMed ID: 2427548
[TBL] [Abstract][Full Text] [Related]
9. How lab staff and the estimation of free light chains can combine to aid the diagnosis of light chain disease.
Sinclair D; Wainwright L
Clin Lab; 2007; 53(5-6):267-71. PubMed ID: 17605400
[TBL] [Abstract][Full Text] [Related]
10. [Research Advances in Treatment of Myeloma Nephropathy-Review].
Zhang XP; Xia ZY; Chen BA; Gao C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):613-616. PubMed ID: 28446322
[TBL] [Abstract][Full Text] [Related]
11. Light-chain nephropathy.
Fang LS
Kidney Int; 1985 Mar; 27(3):582-92. PubMed ID: 3923250
[No Abstract] [Full Text] [Related]
12. Renal crystal storing histiocytosis in a patient with multiple myeloma.
Farooq U; Bayerl MG; Abendroth CS; Verma N; Talamo G
Ann Hematol; 2009 Aug; 88(8):807-9. PubMed ID: 19119476
[No Abstract] [Full Text] [Related]
13. [Non-amyloid nephrotic syndrome: first isolated manifestation of a kappa light chain myeloma (author's transl)].
Mignon F; Vasmant D; Richet G; Wang A; Morel-Maroger L; Brouet JC
Ann Med Interne (Paris); 1979; 130(11):513-6. PubMed ID: 121516
[TBL] [Abstract][Full Text] [Related]
14. [Quantitation of the urinary L-chain multiple myeloma (author's transl)].
Tominaga K
Rinsho Byori; 1976 Apr; 24(4):294. PubMed ID: 819682
[No Abstract] [Full Text] [Related]
15. [Determination of free kappa and lambda light chains in urine by immunoenzyme analysis].
León VJ; León E; Martínez-Pescador R; López-Borrasca A
Sangre (Barc); 1986; 31(3):311-6. PubMed ID: 3092374
[No Abstract] [Full Text] [Related]
16. [Renal disease in multiple myeloma].
Hiromura K; Nojima Y
Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
[TBL] [Abstract][Full Text] [Related]
17. [Light chain myeloma: clinical study and prognostic factors ].
Redón J; Caballero M; Herranz C
Med Clin (Barc); 1982 Jun 16-30; 79(2):54-8. PubMed ID: 6811809
[No Abstract] [Full Text] [Related]
18. Extracorporeal Removal of Light Chains: New Data and Continued Controversies.
Finkel KW; Gallieni M
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1753-1754. PubMed ID: 30348812
[No Abstract] [Full Text] [Related]
19. [Update in multiple myeloma: international criteria for treatment response and renal complications].
Decaux O; Karras A
Rev Med Interne; 2009 Dec; 30(12):1080-3. PubMed ID: 19833418
[No Abstract] [Full Text] [Related]
20. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
